Life365 Continues to Build Upon Its Hospital@Home Product Offering with Eat Fit Go Partnership

SCOTTSDALE, AZ, April 6, 2021— Life365, a leading virtual care platform provider, announced its partnership with EAT FIT GO Wellness, a healthy lifestyles company that empowers wellbeing from the inside out with premium, convenient and healthy nutrition. EAT FIT GO specializes in ready to heat and serve healthy prepackaged meals designed to be affordable, convenient and nutritious.

Continue reading

NIH clinical trial evaluating Moderna COVID-19 variant vaccine begins

Early-stage trial to evaluate safety and immunogenicity.

In investigational vaccine designed to protect against the B.1.351 SARS-CoV-2 variant has been administered as part of a new Phase 1 clinical trial evaluating the vaccine candidate’s safety and immunogenicity in adult volunteers. The vaccine, known as mRNA-1273.351, was developed by the biotechnology company ModernaTX, Inc., based in Cambridge, Massachusetts. The trial is led and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The trial will enroll approximately 210 healthy adult volunteers at four clinical research sites in the United States that are part of the NIAID-funded Infectious Diseases Clinical Research Consortium(IDCRC).

Continue reading

BD Announces FDA Emergency Use Authorization for Combination COVID-19, Flu Rapid Antigen Test

New Test on the BD Veritor™ Plus System Can Detect SARS-CoV-2, Influenza A, Influenza B from Single Patient Sample

FRANKLIN LAKES, N.J., March 30, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted emergency use authorization (EUA) for a new, rapid antigen test that can detect SARS-CoV-2, influenza A and influenza B in a single test.

Continue reading

Mayo Clinic and ASU MedTech Accelerator boosts health startups

The partnership propels a new cohort of next-generation medical technology and service startups forward with one-of-a-kind tools and resources.

Few things have better illustrated the need for innovative medical technologies than the COVID-19 pandemic. The Mayo Clinic and ASU MedTech Accelerator, a flagship program of the Mayo Clinic and ASU Alliance for Health Care, was designed to help empower medical startups to better navigate challenges while bringing forth life-changing health innovations. The second cohort of this program is set to launch March 30, 2021.

Continue reading

Life365 Adds AliveCor’s Personal EKG Technology to their Virtual Care Platform

SCOTTSDALE, AZ, March 30, 2021— Life365, a leading virtual care platform provider, announced its integration of products from AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, to enhance their remote cardiac monitoring solutions for healthcare consumers and patients located outside traditional care settings.

Continue reading

Equine Amnio Solutions Signs Exclusive Agreement For Distribution Of RenoVō®, A Next-Generation Equine Regenerative Product

ARGYLE, Texas, March 25, 2021 /PRNewswire/ — Equine Amnio Solutions, LLC (EAS), a distributor of advanced, next-generation equine regenerative products, announced today that Covetrus, a global leader in animal-health technology and services, will be the exclusive distributor of the RenoVō® equine allograft throughout the United States.

Continue reading

CND Life Sciences Closes Series Seed Funding Round

Innovators of the Syn-One Test™ Building Market Presence and Infrastructure

PHOENIX, AZ — March 23, 2021 — CND Life Sciences, Inc. (https://cndlifesciences.com/), an innovative medical technology company pioneering the detection, visualization, and quantification of protein deposition in cutaneous nerve fibers, announced today the closing of a $2.4 million series seed financing round. HonorHealth, a local health system serving 1.6 million people in the greater Phoenix area, joined several experienced financial investors in funding the round.

Continue reading

New Study Analyzes Potential Impact of Various Drug Pricing Proposals

The Council of State Bioscience Associations (CSBA) today, released data analyzing the potential impact of various drug pricing proposals on patient access to lifesaving medicines, future biomedical innovation, and the economic health of the life sciences industry. 

The study, which was conducted by Vital Transformation, an international health economics firm, examines the negative effects of bills like “Lower Drug Costs Now Act of 2019” and other foreign reference pricing models had they been enacted. 

Continue reading